Nova Patents
AT515262T

Use of parthenolide derivatives as antileukemic and cytotoxic agents

Abstract

The present invention relates to compounds of the formula having an antitumor activity: (Wherein, ROne And R2As hereinbefore described in the present application).

Term

Term ended

Expired 9 July 2024, 2.2 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

36 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
48617103United States of AmericaP
2004022015United States of AmericaW

Members36

Family members, oldest first
DocumentOfficeKind
AU2004257696A1AustraliaA1
CA2532229A1CanadaA1
WO2005007103A2World Intellectual Property Organization (WIPO)A2
US2005032886A1United States of AmericaA1
WO2005007103A3World Intellectual Property Organization (WIPO)A3
US2005272716A1United States of AmericaA1
EP1643984A2European Patent Office (EPO)A2
KR20060037340ARepublic of KoreaA
HK1088845AHong Kong, ChinaA
JP2007531695AJapanA
US7312242B2United States of AmericaB2
EP1643984A4European Patent Office (EPO)A4
US7678904B2United States of AmericaB2
US2010184745A1United States of AmericaA1
AU2004257696B2AustraliaB2
EP1643984B1European Patent Office (EPO)B1
JP2011137036AJapanA
AT515262TThis recordAustriaT
ATE515262T1AustriaT1
JP4767848B2JapanB2
DK1643984T3DenmarkT3
ES2369083T3SpainT3
KR101108787B1Republic of KoreaB1
US8124652B2United States of AmericaB2
US2012165308A1United States of AmericaA1
US8470875B2United States of AmericaB2
US2013288371A1United States of AmericaA1
US8716329B2United States of AmericaB2
CA2532229CCanadaC
US2015099731A1United States of AmericaA1
US9045490B2United States of AmericaB2
US2015259356A1United States of AmericaA1
US9447112B2United States of AmericaB2
US2017224698A1United States of AmericaA1
US10251890B2United States of AmericaB2
US2019231790A1United States of AmericaA1